Congress mandates allergy coverage, strips insurers of cost-control tools
H.R. 11024 — Allergy & Asthma Patient Protection Act of 2026 · Filed by Robert Onder (R-MO) · 1 cosponsor · Introduced Nov 12, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires health insurance plans (both group and individual) to cover allergy and asthma diagnostic testing and allergen immunotherapy treatments starting in 2028, without imposing limits on the number of allergens tested, prior authorization barriers, or artificial caps on extract preparation. Patients with allergies and asthma gain access to comprehensive diagnostic and treatment services that insurers cannot restrict based on cost-control measures that conflict with medical standards.
Why we flagged it
The bill's operative mechanism is a mandate requiring insurers to cover specific medical services without cost-control restrictions. It is a consumer-protection measure that expands coverage and removes utilization barriers, not a deregulation or carve-out.
What the text implies
- Insurers may respond by raising premiums for group and individual plans to offset the cost of expanded coverage and removal of cost-control tools, potentially increasing out-of-pocket costs for all enrollees.
- The bill's reliance on 'recognized clinical standards' defined by national medical specialty organizations (ACAAI, AAAAI, etc.) gives those organizations de facto regulatory power over coverage policy without explicit congressional definition.
- Allergen extract manufacturers and allergy/immunology practices stand to gain volume increases as prior authorization and volume-cap barriers are removed, potentially driving higher utilization and costs.
- The 2028 effective date provides a 14-month implementation window; insurers may front-load claims or adjust pricing before the mandate takes effect.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Patients with allergies and asthma gain guaranteed access to diagnostic testing and immunotherapy without insurer-imposed barriers, prior authorization delays, or artificial volume caps that conflict with medical standards. The bill removes cost-control mechanisms that delay or deny care, shifting power from insurers to patients and their physicians.
Who stands to gain
- Allergy and immunology medical practices
- Allergen extract manufacturers
- Diagnostic testing laboratories
- Health insurance plans (if utilization remains lower than feared)
Named in the bill
Group health plans, Health insurance issuers, American College of Allergy, Asthma & Immunology (ACAAI), American Academy of Allergy, Asthma & Immunology (AAAAI), American Academy of Otolaryngic Allergy, CPT codes 95115, 95117, 95165, 95145, 95146, 95147, 95148, 95149, 95180, Public Health Service Act, Title XXVII
Where it stands
1 cosponsor: 1 Republicans.
- Nov 12, 2026 — Introduced · Congress.gov: “Introduced in House”
- Nov 12, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (7,103 characters) on Nov 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-11-22.
“Congress mandates allergy coverage, strips insurers of cost-control tools” QuorumCivic. https://share.quorumcivic.app/bill/119/hr11024 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.